Wellcome Trust - Articles and news items

Mucosis’ needle-free nasal spray vaccine for RSV trial starts

Industry news / 8 November 2016 / Niamh Louise Marriott, Digital Content Producer

Mucosis has begun a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London…

Major global study reveals new hypertension and blood pressure genes

Industry news / 13 September 2016 / Niamh Louise Marriott, Digital Content Producer

The discoveries include DNA changes in three rare genes that have much larger effects on blood pressure in the population than previously seen, providing new insights into the physiology of hypertension and suggesting new targets for treatment…

Antibiotic resistance poorly communicated and widely misunderstood

Industry news / 31 July 2015 / Victoria White

People in the UK have little awareness of what ‘antibiotic resistance’ means, according to new research commissioned by the Wellcome Trust…


Merck Serono to collaborate with The Institute of Cancer Research, London, and Wellcome Trust to co-develop anti-cancer drugs

Industry news / 8 October 2014 / The Wellcome Trust, The Institute of Cancer Research & Merck Serono

Merck Serono, The Institute of Cancer Research, and the Wellcome Trust, London, have announced a co-development and license agreement building on two independent research programs at both the ICR and Merck Serono to identify inhibitors of tankyrase, an enzyme of the poly (ADP-ribose) polymerase family…

GlaxoSmithKline logo

Where do you start when developing a new medicine?

Industry news / 27 March 2014 / GlaxoSmithKline

Novel scientific collaboration to use genomics and big data to drive drug discovery…

University of Dundee Logo

£10 million boost for neglected tropical disease research at Dundee

Industry news, News / 6 March 2012 / University of Dundee

Dundee, GSK and Wellcome Trust enter five-year collaboration for neglected diseases…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...